Form 4 for NAMS NewAmsterdam Pharma Co N.V.
Accepted 2025-09-05 00:00:00 ET · period of report 2025-09-03 · accession 0000950170-25-113276 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-05 | 2025-09-03 | NAMS | Kooij Louise Frederika | CAO | S - Sale | $25.09 | -18.1K | 15.0K | -55% | -$453.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-09-03 | S | D | 18,073 | $25.09 | 15,000 | D | — | — | (F1) The price reported in Column 4 is a weighted average price provided by the broker; additional information, including the price range, if any, is unavailable at the time of filing. |